Evidence map›Paper›PMID 32696269›Full record

ArticleJournal of medical systems2020

The Modern Pneumatic Tube System Transports with Reduced Speed Does Not Affect Special Coagulation Tests.

Luděk Slavík, Jana Úlehlová, Pavla Bradáčová, Kateřina Chasáková, Antonín Hluší, Miroslava Palová, Alice Entrová

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Luděk SlavíkDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic. ludek.slavik@fnol.cz.ORCID http://orcid.org/0000-0001-5904-759X
Jana ÚlehlováDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
Pavla BradáčováDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
Kateřina ChasákováDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
Antonín HlušíDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
Miroslava PalováDepartment of Hemato-Oncology, Palacký University Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
Alice EntrováDepartment of Blood Transfusion, University Hospital Olomouc, Olomouc, Czech Republic.
University Hospital Olomouc · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumatic tube transport systems (PTS) for delivery of patient samples to a hemostasis laboratory are often used to reduce turnaround time for vital analyses. PTS in our hospital has the ability to regulate the transport speed in the range of 3-6 m/s with acceleration control technology. We evaluated the effects of PTS transport for routine coagulation tests, platelet function tests and special global coagulation tests. Duplicate samples were collected from 29 patients and 40 healthy individuals. One sample was sent using PTS and the other was carried by personnel to the lab for determination of protrombin time, activated partial thromboplastin time, trombin time, fibrinogen, antitrombin and thrombin generation test. Platelet function was measured by means of a Apact 4004® analyzer using the inductors (ADP, Arachidonic acid and Epinephrine). Samples transported using PTS with normal transport speed 6 m/s does not affect basic coagulation tests (PT, aPTT, FIB, TT and AT), but TGT has significantly altered. The use of PTS with controlled acceleration regulated the increase in thrombin generation from 10% to 3%, which is not statistically signifiant. The use of PTS with controlled acceleration did not show a significant difference even with the highly sensitive method of platelet aggregation. We conclude that PTS with acceleration control with transport speed from 3 to 6 m/s does not affect to platelet activity as measured by LTA and also global coagulation test - TGT. The advantage of PTS transport is very rapid assessment laboratory testing. From the above validation study, it is clear that PTS should always be validated for specialized laboratory methods and appropriately adapted to specific transport conditions.

Indexed as

Blood PlateletsPlatelet AggregationBlood Coagulation TestsHumansControlled accelerationPlateletPneumatic tube system

Identifiers

PMID32696269
OpenAlexW3044771440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.